Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Gross Margin (2016 - 2025)

Historic Gross Margin for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to 40.14%.

  • Marimed's Gross Margin fell 12000.0% to 40.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 38.37%, marking a year-over-year decrease of 43800.0%. This contributed to the annual value of 39.8% for FY2024, which is 45600.0% down from last year.
  • According to the latest figures from Q3 2025, Marimed's Gross Margin is 40.14%, which was down 12000.0% from 40.47% recorded in Q2 2025.
  • Marimed's 5-year Gross Margin high stood at 59.58% for Q2 2021, and its period low was 32.93% during Q4 2024.
  • In the last 5 years, Marimed's Gross Margin had a median value of 44.52% in 2023 and averaged 45.62%.
  • Examining YoY changes over the last 5 years, Marimed's Gross Margin showed a top increase of 7600bps in 2022 and a maximum decrease of -141000bps in 2022.
  • Marimed's Gross Margin (Quarter) stood at 49.9% in 2021, then fell by -12bps to 44.13% in 2022, then rose by 1bps to 44.52% in 2023, then fell by -26bps to 32.93% in 2024, then grew by 22bps to 40.14% in 2025.
  • Its last three reported values are 40.14% in Q3 2025, 40.47% for Q2 2025, and 39.88% during Q1 2025.